A carregar...
Mechanisms of Resistance to the Third-generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer
Targeted therapy of epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKIs) has been the standard modality as first-line treatment of advanced EGFR-mutated non-small cell lung cancer (NSCLC). The third-generation EGFR-TKIs has been approved to overcome the EGFR T790M mutation in patie...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Chinês |
| Publicado em: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2018-02-01
|
| Colecção: | Chinese Journal of Lung Cancer |
| Assuntos: | |
| Acesso em linha: | http://dx.doi.org/10.3779/j.issn.1009-3419.2018.02.02 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|